Long-term follow-up of the cognitive function in children after intravitreal ranibizumab for retinopathy of prematurity-Reference-Cited by-同舟云学术

Long-term follow-up of the cognitive function in children after intravitreal ranibizumab for retinopathy of prematurity

Published:2024-04-21 Issue: Volume: Page:
ISSN:0721-832X
Container-title:Graefe's Archive for Clinical and Experimental Ophthalmology
language:en
Short-container-title:Graefes Arch Clin Exp Ophthalmol

Author:

Tian Ya,Fan Zixin,Zeng Xianlu,Yu Zhen,Lu Xiaofeng,Zhao Xinyu,Wu Zhenquan,He Honghui,Zeng Jian,Zheng Lei,Zhang Linlin,Correa Victor S. M. C.,Ying Guishuang,Zhang Shaochong,Zhang Guoming^ORCID

Funder

National Natural Science Foundation of China

Basic and Applied Basic Research Foundation of Guangdong Province

Shenzhen Science and Technology Innovation Program

Shenzhen Key Laboratory for Advanced Quantum Dot Displays and Lighting

Shenzhen Key Laboratory Fund

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00417-024-06486-x.pdf

Reference31 articles.

1. Norman M, Hellström A, Hallberg B, Wallin A, Gustafson P, Tornqvist K, Håkansson S, Holmström G (2019) prevalence of severe visual disability among preterm children with retinopathy of prematurity and association with adherence to best practice guidelines. JAMA Netw Open 2(1):e186801

2. Bashinsky AL (2017) Retinopathy of prematurity. N C Med J 78(2):124–128

3. Sen P, Wu WC, Chandra P, Vinekar A, Manchegowda PT, Bhende P (2020) Retinopathy of prematurity treatment: Asian perspectives. Eye (Lond) 34(4):632–642

4. Rattner A, Wang Y, Nathans J (2022) Signaling pathways in neurovascular development. Annu Rev Neurosci 45:87–108

5. Wu WC, Shih CP, Lien R, Wang NK, Chen YP, Chao AN, Chen KJ, Chen TL, Hwang YS, Lai CC (2017) Serum vascular endothelial growth factor after bevacizumab or ranibizumab treatment for retinopathy of prematurity. Retina 37:694–701